Archives

Amgen is cutting the list price of its new cholesterol-lowering drug by nearly 60 percent, a move the company says

More technology startups are embracing the healthcare industry’s increasing willingness to pay for products based on how much they improve

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-EIC-FTI-2018-2020Pillar: Industrial LeadershipOpening Date: Deadline: Tue, 23 Oct 2018 17:00:00 (Brussels local time)Modification Date: Wed, 24 Oct

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: EMFF-BlueEconomy-2018Pillar: EMFF-1-1Opening Date: Deadline: Thu, 31 Jan 2019 17:00:00 (Brussels local time)Modification Date: Tue, 23 Oct 2018Latest

Cancer testing laboratory Genoptix is being acquired by NeoGenomics, another cancer-focused genetic testing business, for $125 million in cash and

[Source: Research & Innovation] The Enterprise Europe Network in partnership with the Science and Innovation Network, BEIS, Innovate UK and

The Centers for Medicare & Medicaid Services (CMS) has reversed a long-standing policy allowing Medicare Advantage plans to impose “step

Centrexion Therapeutics is notable for focusing solely on developing non-opioid, non-addictive pain drugs-an area that biopharma companies have largely avoided.

Each year, roughly 12,500 newborns in the U.S., or one out of every 300 infants, are diagnosed with one of

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-INNOSUP-2018-2020Pillar: Industrial LeadershipOpening Date: Deadline: Thu, 12 Apr 2018 17:00:00 (Brussels local time)Modification Date: Mon, 22 Oct